398 related articles for article (PubMed ID: 25545350)
1. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
[TBL] [Abstract][Full Text] [Related]
2. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
[TBL] [Abstract][Full Text] [Related]
3. Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis.
Kim DH; Kim J; Lee JW
Mol Endocrinol; 2011 Dec; 25(12):2076-83. PubMed ID: 22034226
[TBL] [Abstract][Full Text] [Related]
4. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
5. Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.
Kim DH; Kwon S; Byun S; Xiao Z; Park S; Wu SY; Chiang CM; Kemper B; Kemper JK
Nat Commun; 2016 Jul; 7():12179. PubMed ID: 27412403
[TBL] [Abstract][Full Text] [Related]
6. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.
Fang S; Miao J; Xiang L; Ponugoti B; Treuter E; Kemper JK
Mol Cell Biol; 2007 Feb; 27(4):1407-24. PubMed ID: 17145766
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
8. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
9. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
10. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
Hu X; Bonde Y; Eggertsen G; Rudling M
J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
[TBL] [Abstract][Full Text] [Related]
13. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
[TBL] [Abstract][Full Text] [Related]
15. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
[TBL] [Abstract][Full Text] [Related]
16. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
[TBL] [Abstract][Full Text] [Related]
17. Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically co-repress CYP7A1 transcription.
Ouyang H; Qin Y; Liu Y; Xie Y; Liu J
PLoS One; 2013; 8(4):e62192. PubMed ID: 23626788
[TBL] [Abstract][Full Text] [Related]
18. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
[TBL] [Abstract][Full Text] [Related]
19. Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver.
Lickteig AJ; Csanaky IL; Pratt-Hyatt M; Klaassen CD
Toxicol Sci; 2016 Jun; 151(2):403-18. PubMed ID: 26984780
[TBL] [Abstract][Full Text] [Related]
20. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
